Announced Tue, 13 Oct, 2026 · 17:47 IST

Routine RTA confirmation certificate filing for Q2 FY27

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.9%Reaction day
₹31.55
prior close
₹31.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+0.2% vs market
Non Banking Financial Company (NBFC) peers, median of 209sector+0.0%+0.9% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.9 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.2
10m
+3.2
15m
+1.8
30m
+3.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.9+0.7+0.2+0.0+0.9
Next day
+0.5-1.0+1.4-0.0+0.5
2d
+9.0-0.3+9.2-0.3+9.3
3d
+4.2-1.9+6.1-0.7+4.9
4d
+4.6-4.5+9.1-2.3+6.8
5d
+4.4-5.5+9.9-3.2+7.6
1w
+10.9-7.3+18.2-5.3+16.2
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 209Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Prism Medico and Pharmacy has submitted a confirmation certificate from its Registrar and Share Transfer Agent, Purva Sharegistry, under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The RTA confirms that all dematerialisation requests received from depository participants during the quarter were processed within the required timelines, with no share certificates dematerialised during this period. This is a standard quarterly compliance filing.

Likely market impact

Routine compliance filing with no material impact on shareholders or the stock. No dematerialisation activity reported this quarter.